USANA HEALTH SCIENCES INC's ticker is USNA and the CUSIP is 90328M107. A total of 141 filers reported holding USANA HEALTH SCIENCES INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $624 | 0.0% | 10,639 | +7.4% | 0.00% | 0.0% |
Q2 2023 | $624 | -3.3% | 9,902 | -3.5% | 0.00% | -50.0% |
Q1 2023 | $645 | +9.9% | 10,260 | -7.0% | 0.00% | 0.0% |
Q4 2022 | $587 | -99.9% | 11,033 | -16.2% | 0.00% | 0.0% |
Q3 2022 | $738,000 | -10.5% | 13,167 | +15.5% | 0.00% | 0.0% |
Q2 2022 | $825,000 | -2.1% | 11,404 | +10.3% | 0.00% | 0.0% |
Q1 2022 | $843,000 | -19.9% | 10,338 | -0.7% | 0.00% | 0.0% |
Q4 2021 | $1,052,000 | +10.2% | 10,406 | +1.1% | 0.00% | 0.0% |
Q3 2021 | $955,000 | -9.4% | 10,292 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $1,054,000 | +2.3% | 10,292 | -2.5% | 0.00% | -33.3% |
Q1 2021 | $1,030,000 | +12.1% | 10,560 | -11.4% | 0.00% | +50.0% |
Q4 2020 | $919,000 | -10.5% | 11,915 | -14.5% | 0.00% | 0.0% |
Q3 2020 | $1,027,000 | -7.3% | 13,937 | -7.8% | 0.00% | -33.3% |
Q2 2020 | $1,108,000 | +17.5% | 15,108 | -7.7% | 0.00% | 0.0% |
Q1 2020 | $943,000 | -25.9% | 16,371 | +0.2% | 0.00% | 0.0% |
Q4 2019 | $1,273,000 | +777.9% | 16,337 | +789.8% | 0.00% | – |
Q2 2019 | $145,000 | +14.2% | 1,836 | +21.1% | 0.00% | – |
Q1 2019 | $127,000 | -26.2% | 1,516 | 0.0% | 0.00% | – |
Q4 2018 | $172,000 | +35.4% | 1,516 | +43.8% | 0.00% | – |
Q3 2018 | $127,000 | +4.1% | 1,054 | 0.0% | 0.00% | – |
Q2 2018 | $122,000 | +34.1% | 1,054 | 0.0% | 0.00% | – |
Q1 2018 | $91,000 | +16.7% | 1,054 | 0.0% | 0.00% | – |
Q4 2017 | $78,000 | +27.9% | 1,054 | 0.0% | 0.00% | – |
Q3 2017 | $61,000 | -9.0% | 1,054 | 0.0% | 0.00% | – |
Q2 2017 | $67,000 | +9.8% | 1,054 | 0.0% | 0.00% | – |
Q1 2017 | $61,000 | -6.2% | 1,054 | 0.0% | 0.00% | – |
Q4 2016 | $65,000 | -55.5% | 1,054 | 0.0% | 0.00% | – |
Q3 2016 | $146,000 | +147.5% | 1,054 | +100.0% | 0.00% | – |
Q2 2016 | $59,000 | -59.3% | 527 | -56.1% | 0.00% | -100.0% |
Q1 2016 | $145,000 | -5.2% | 1,200 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $153,000 | -5.0% | 1,200 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $161,000 | -1.2% | 1,200 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $163,000 | +22.6% | 1,200 | 0.0% | 0.00% | – |
Q1 2015 | $133,000 | +8.1% | 1,200 | 0.0% | 0.00% | – |
Q4 2014 | $123,000 | +36.7% | 1,200 | -0.7% | 0.00% | – |
Q3 2014 | $90,000 | +8900.0% | 1,209 | +13333.3% | 0.00% | – |
Q2 2014 | $1,000 | – | 9 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Euclidean Technologies Management, LLC | 34,732 | $3,563,000 | 3.33% |
Matarin Capital Management, LLC | 28,322 | $2,905,554,000 | 1.28% |
Capital Impact Advisors, LLC | 21,373 | $2,193,000 | 1.03% |
USA FINANCIAL FORMULAS | 20,088 | $2,061,000 | 0.71% |
Camarda Financial Advisors, LLC | 8,951 | $918,000 | 0.58% |
Invictus RG Pte. Ltd. | 4,862 | $499,000 | 0.54% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 78,238 | $8,026,000 | 0.53% |
Wolf Group Capital Advisors | 6,696 | $687,000 | 0.50% |
RQSI Ltd | 3,937 | $404,000 | 0.38% |
CLARK ESTATES INC/NY | 23,759 | $2,437,000 | 0.36% |